[Extra- and intracellular mechanisms of changes in erythrocyte aggregation].
Murav'ev
A V
AV
Murav'ev
A A
AA
D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D003994:Bucladesine / Q000494:pharmacology; D002395:Catecholamines / Q000502:physiology*; D000242:Cyclic AMP / Q000502:physiology*; D003563:Cyclic CMP / Q000031:analogs & derivatives / Q000494:pharmacology; D004903:Erythrocyte Aggregation / Q000187:drug effects / Q000502:physiology*; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D002395:Catecholamines; D010726:Phosphodiesterase Inhibitors; D003563:Cyclic CMP; D003994:Bucladesine; C053441:dibutyryl cyclic-3',5'-cytidine monophosphate; D010208:Papaverine; D000242:Cyclic AMP